Parallax Volatility Advisers’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-53,800
Closed -$1.82M 1784
2024
Q4
$1.82M Buy
53,800
+23,900
+80% +$860K ﹤0.01% 1151
2024
Q3
$1.22M Buy
+29,900
New +$1.22M ﹤0.01% 1301
2023
Q1
Sell
-17,500
Closed -$615K 2904
2022
Q4
$615K Hold
17,500
﹤0.01% 1817
2022
Q3
$515K Sell
17,500
-76,260
-81% -$2.89M ﹤0.01% 1970
2022
Q2
$5.1M Buy
93,760
+86,160
+1,134% +$4.76M ﹤0.01% 970
2022
Q1
$414K Sell
7,600
-24,800
-77% -$1.35M ﹤0.01% 1965
2021
Q4
$1.79M Sell
32,400
-240
-0.7% -$12.5K ﹤0.01% 1112
2021
Q3
$1.56M Buy
+32,640
New +$1.64M ﹤0.01% 1204
2021
Q1
Sell
-11,760
Closed -$541K 1463
2020
Q4
$541K Sell
11,760
-9,120
-44% -$419K ﹤0.01% 1637
2020
Q3
$985K Buy
20,880
+11,360
+119% +$569K ﹤0.01% 1990
2020
Q2
$484K Buy
+9,520
New +$488K ﹤0.01% 1989
2019
Q1
Sell
-4,560
Closed -$218K 3246
2018
Q4
$218K Buy
+4,560
New +$225K ﹤0.01% 1721
2015
Q3
Sell
-68,160
Closed -$3.55M 3352
2015
Q2
$3.55M Buy
68,160
+68,000
+42,500% +$3.83M 0.01% 846
2015
Q1
$9K Buy
+160
New +$9.17K ﹤0.01% 3956

Other funds holding GSK